Speaking with French newspaper Le Figaro, Pfizer Chief Executive Officer Albert Bourla said he believes the world will “return to normal life” sometime during the spring of 2022.
If you are not happy with the results below please do another search
50 search results for:
A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a preliminary study in Israel.
Building on Novo Nordisk’s success during June 2021 in obtaining the first drug approval for weight management since 2014, the Danish pharma giant is partnering with biotech company EraCal Therapeutics to develop new obesity-related drug targets.
GlaxoSmithKline declined all three of Unilever’s offers to acquire GSK’s consumer healthcare business, saying the proposal undervalued the division’s present and further worth.
On January 17, America is celebrating the legendary life of civil rights leader Dr. Martin Luther King Jr. In 2022, the holiday comes in the wake of two years of racial tensions and protests, and the racial inequities exposed by the COVID-19 pandemic. BioSpace is marking the occasion by sharing some of its recent coverage about what the life sciences industry is doing to even those scales.
The U.S. Centers for Disease Control and Prevention on Jan. 14 revised the CDC’s guidance for Americans on wearing masks to protect against COVID-19, recommending donning “the most protective mask you can” while stopping short of advocating nationwide usage of N95 respirators.
The COVAX global vaccine-sharing program has delivered 1 billion COVID-19 vaccine doses, one of the organizations which manages it said on January 15.
U.S. households can order four free at-home COVID-19 tests from the website COVIDTests.gov starting on Jan. 19 with shipping expected within seven to 12 days of ordering, the White House said on Jan. 14.
The U.S. Food and Drug Administration approved drugs from AbbVie Inc. and Pfizer Inc. for treating the skin disease eczema, the companies said on Jan. 14.
After a five-day quarantine, about a third of people infected with SARS-CoV-2 might still be infectious, according to new data. In other news, according to research published in the Journal of Primary Care & Community Health, e-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms